| Title |
The prevalence and incidence of medicinal cannabis on prescription in The Netherlands
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, April 2013
|
| DOI | 10.1007/s00228-013-1503-y |
| Pubmed ID | |
| Authors |
Arno Hazekamp, Eibert R. Heerdink |
| Abstract |
A growing number of countries are providing pharmaceutical grade cannabis to chronically ill patients. However, little published data is known about the extent of medicinal cannabis use and the characteristics of patients using cannabis on doctor's prescription. This study describes a retrospective database study of The Netherlands. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 192 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 1% |
| United Kingdom | 1 | <1% |
| Unknown | 189 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 26 | 14% |
| Student > Ph. D. Student | 25 | 13% |
| Student > Master | 24 | 13% |
| Student > Bachelor | 24 | 13% |
| Other | 21 | 11% |
| Other | 26 | 14% |
| Unknown | 46 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 44 | 23% |
| Agricultural and Biological Sciences | 22 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 17 | 9% |
| Psychology | 9 | 5% |
| Biochemistry, Genetics and Molecular Biology | 7 | 4% |
| Other | 34 | 18% |
| Unknown | 59 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2016.
All research outputs
#1,607,785
of 23,577,654 outputs
Outputs from European Journal of Clinical Pharmacology
#88
of 2,597 outputs
Outputs of similar age
#12,074
of 176,605 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#2
of 23 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,597 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,605 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.